← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Vesicle Therapeutics Inc.
Niwot, CO
$1,619,820
Total funding
4
Grants
Funding over time
peak $1.2M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$1,619,820 · 4
By mechanism
R41$716,823 · 2
N43$475,152 · 1
R43$427,845 · 1
Investigators at Vesicle Therapeutics Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
NEUROTROPIC GECTOSOMES AS A CNS GENE DELIVERY SYSTEM FOR AD/ADRD THERAPY DEVELOPMENT$475,152
N43 · FY2022 · DA
Targeting STAT3 with Novel Thiomorpholino Antisense Oligonucleotides for Cancer Therapy$400,000
R41 · FY2025 · CA
Development of a Gectosome Therapy for Cardiovascular Diseases$316,823
R41 · FY2022 · HL
Targeting GPR146 for the Treatment of Homozygous Familial Hypercholesterolemia$298,036
R43 · FY2022 · HL
Targeting GPR146 for the Treatment of Homozygous Familial Hypercholesterolemia$129,809
R43 · FY2022 · HL